NASDAQ:CALA • US13089P5070
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CALITHERA BIOSCIENCES INC (CALA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-15 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2022-11-15 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-08-29 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2022-08-16 | SVB Leerink | Maintains | Outperform |
| 2022-05-11 | Wells Fargo | Maintains | Equal-Weight |
| 2022-01-31 | Ladenburg Thalmann | Initiate | Buy |
| 2022-01-20 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-11-08 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-11-05 | William Blair | Downgrade | Outperform -> Market Perform |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 9.75M | -100.00% | 252.95M | 519.63M 105.43% | 800.59M 54.07% | ||||
| EBITDA YoY % growth | -92.42M -62.80% | -91.03M 1.50% | -113.953M -25.18% | -58.14M 48.98% | -59.262M -1.93% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -92.9M -62.19% | -91.39M 1.63% | -114.233M -25.00% | -44.421M 61.11% | -35.79M 19.43% | -35M 2.21% | -66.629M -90.37% | -25.981M 61.01% | 30.023M 215.56% | |
| Operating Margin | N/A | N/A | -1,171.62% | N/A | N/A | N/A | -26.34% | -5.00% | 3.75% | |
| EPS YoY % growth | -39.20 -31.54% | -26.20 33.16% | -17.20 34.35% | -5.27 69.34% | -1.52 71.08% | -1.69 -10.70% | -2.15 -27.49% | -0.79 63.51% | 0.86 209.09% |
All data in USD
| Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.52 68.34% | -0.53 85.35% | -0.29 81.91% | -0.28 86.15% | -0.28 81.41% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.231M 86.66% | -8.769M 36.58% | -8.33M 26.77% | -8.748M 8.17% | -9.185M 0.50% |
All data in USD
10 analysts have analysed CALA and the average price target is 5.1 USD. This implies a price increase of 1296.88% is expected in the next year compared to the current price of 0.3651.
CALITHERA BIOSCIENCES INC (CALA) will report earnings on 2023-03-29, after the market close.
The consensus EPS estimate for the next earnings of CALITHERA BIOSCIENCES INC (CALA) is -1.52 USD and the consensus revenue estimate is 0 USD.
The expected long term growth rate for CALITHERA BIOSCIENCES INC (CALA) is -25.99%.